Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Marzo

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Clinical Breast Cancer|October 30, 2020
Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial)Davide Franceschini, Mauro Loi, Ilaria Chiola, et al.
Cancers|April 9, 2020
Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung CancerMauro Loi, Davide Franceschini, Luca Dominici, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2020
Salvage radiotherapy for oligo-progressive malignant pleural mesotheliomaPaolo Ghirardelli, Davide Franceschini, Alessandro D'Aveni, et al.
Cancers|February 13, 2026
The Role of Dosimetric Parameters in Radiation Pneumonitis: A Functional Approach in Adjuvant Treatment of Malignant Pleural MesotheliomaLuca Dominici, Davide Franceschini, Mauro Loi, et al.
Diseases (Basel, Switzerland)|July 26, 2024
STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung LesionsDavide Franceschini, Mauro Loi, Antonio Marco Marzo, et al.
Oncotarget|September 29, 2018
Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II studyFrancesca De Felice, Giancarlo D'Ambrosio, Daniela Musio, et al.
Cancers|January 25, 2025
Cardiac Exposure Related to Adjuvant Radiotherapy in Patients Affected by Thymoma: A Dosimetric Comparison of Photon or Proton Intensity-Modulated TherapyAntonio Marco Marzo, Luca Cozzi, Davide Franceschini, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 24, 2020
Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapyMauro Loi, Davide Franceschini, Luca Dominici, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2020
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancingPierina Navarria, Federico Pessina, Ciro Franzese, et al.
Environment International|July 9, 2018
(Eco)toxicological maps: A new risk assessment method integrating traditional and in silico tools and its application in the Ledra River (Italy)Giuseppa Raitano, Daniele Goi, Valentina Pieri, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Clinical Breast Cancer|October 30, 2020
Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial)Davide Franceschini, Mauro Loi, Ilaria Chiola, et al.
Cancers|April 9, 2020
Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung CancerMauro Loi, Davide Franceschini, Luca Dominici, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2020
Salvage radiotherapy for oligo-progressive malignant pleural mesotheliomaPaolo Ghirardelli, Davide Franceschini, Alessandro D'Aveni, et al.
Cancers|February 13, 2026
The Role of Dosimetric Parameters in Radiation Pneumonitis: A Functional Approach in Adjuvant Treatment of Malignant Pleural MesotheliomaLuca Dominici, Davide Franceschini, Mauro Loi, et al.
Diseases (Basel, Switzerland)|July 26, 2024
STRILL: Phase I Trial Evaluating Stereotactic Body Radiotherapy (SBRT) Dose Escalation for Re-Irradiation of Inoperable Peripheral Lung LesionsDavide Franceschini, Mauro Loi, Antonio Marco Marzo, et al.
Oncotarget|September 29, 2018
Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II studyFrancesca De Felice, Giancarlo D'Ambrosio, Daniela Musio, et al.
Cancers|January 25, 2025
Cardiac Exposure Related to Adjuvant Radiotherapy in Patients Affected by Thymoma: A Dosimetric Comparison of Photon or Proton Intensity-Modulated TherapyAntonio Marco Marzo, Luca Cozzi, Davide Franceschini, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 24, 2020
Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapyMauro Loi, Davide Franceschini, Luca Dominici, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2020
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancingPierina Navarria, Federico Pessina, Ciro Franzese, et al.
Environment International|July 9, 2018
(Eco)toxicological maps: A new risk assessment method integrating traditional and in silico tools and its application in the Ledra River (Italy)Giuseppa Raitano, Daniele Goi, Valentina Pieri, et al.
Pageof 4